Yesterday, a jury in a Missouri state court ordered healthcare products company Johnson and Johnson to pay $55 million dollars to a woman who claimed that she developed ovarian cancer after using the company’s talc products for feminine hygiene purposes.
The city of Orlando, Florida and its fire department are facing tens of thousands of dollars in fines for exposing firefighters to toxic asbestos during preparations for a training exercise back in February.
Results of a Phase 1B clinical trial presented earlier this week at the 2016 European Lung Cancer Conference in Geneva, Switzerland demonstrate that a new immunotherapy treatment using live bacterium might eventually become a treatment of choice for individuals suffering from malignant pleural mesothelioma.
An asbestos related lawsuit filed by a decades-long employee of Sonoma State University in Rohnert Park, California has many students, staff, and administration up in arms about the safety of several buildings on this pretty campus located just an hour north of San Francisco and nestled in the bucolic wine country of the Golden State.
Mesothelioma has long been one of the most difficult forms of cancer to treat. Hard to detect until its late stages, due to an extended latency period, it almost always appears in Stage 3 or 4 when mesothelioma treatment options are fewer and the disease has progressed to the point where metastases is nearly always present. Chemo and radiation may be able to relieve some of the symptoms of the disease and surgery is sometimes an option. Still, the life expectancy remains short for most mesothelioma patients.